+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Renal Biomarkers Market by Marker Type (Blood Urea Nitrogen, Creatinine, Cystatin C), Assay Platform Type (Enzymatic Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Turbidimetric Immunoassay), Application, End-User - Forecast 2024-2030- Product Image
Global Renal Biomarkers Market by Marker Type (Blood Urea Nitrogen, Creatinine, Cystatin C), Assay Platform Type (Enzymatic Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Turbidimetric Immunoassay), Application, End-User - Forecast 2024-2030- Product Image
Sale

Global Renal Biomarkers Market by Marker Type (Blood Urea Nitrogen, Creatinine, Cystatin C), Assay Platform Type (Enzymatic Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Turbidimetric Immunoassay), Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 180 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5888834
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Renal Biomarkers Market size was estimated at USD 1.33 billion in 2023, USD 1.43 billion in 2024, and is expected to grow at a CAGR of 7.72% to reach USD 2.24 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Renal Biomarkers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Renal Biomarkers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Renal Biomarkers Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Bayer AG, Bio-Rad Laboratories, Inc., bioMérieux SA, BioPorto Diagnostics A/S, Cipla Limited, Danaher Corporation, DiaSorin S.p.A., Eli Lilly and Co, Enzo Biochem, Inc., Eurofins Viracor Inc., F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, Novartis AG, Novatein Biosciences Inc., PerkinElmer Inc., Randox Laboratories Ltd., Renalytix AI PLC, Sanofi-Aventis, LLC., Sekisui Diagnostics, LLC, Siemens Healthineers AG, SphingoTec GmbH, and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Renal Biomarkers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Marker Type
    • Blood Urea Nitrogen
    • Creatinine
    • Cystatin C
    • Neutrophil Gelatinase-Associated Lipocalin
  • Assay Platform Type
    • Enzymatic Assay
    • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Turbidimetric Immunoassay
  • Application
    • Diagnosis & Disease Progression Monitoring
    • Research
  • End-User
    • Diagnostic Laboratories
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Renal Biomarkers Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Renal Biomarkers Market?
  3. What are the technology trends and regulatory frameworks in the Renal Biomarkers Market?
  4. What is the market share of the leading vendors in the Renal Biomarkers Market?
  5. Which modes and strategic moves are suitable for entering the Renal Biomarkers Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Renal Biomarkers Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of renal disorders among population
5.1.1.2. Growing initiatives to create awareness on renal diseases and renal biomarkers
5.1.1.3. Trend towards developing personalized medicines and targeted therapies
5.1.2. Restraints
5.1.2.1. High costs associated with renal biomarkers
5.1.3. Opportunities
5.1.3.1. Robust research activities to introduce new renal biomarkers
5.1.3.2. Emerging technological advancements in renal surgeries
5.1.4. Challenges
5.1.4.1. Concerns over failure of biomarkers
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Renal Biomarkers Market, by Marker Type
6.1. Introduction
6.2. Blood Urea Nitrogen
6.3. Creatinine
6.4. Cystatin C
6.5. Neutrophil Gelatinase-Associated Lipocalin
7. Renal Biomarkers Market, by Assay Platform Type
7.1. Introduction
7.2. Enzymatic Assay
7.3. Enzyme-Linked Immunosorbent Assay (ELISA)
7.4. Turbidimetric Immunoassay
8. Renal Biomarkers Market, by Application
8.1. Introduction
8.2. Diagnosis & Disease Progression Monitoring
8.3. Research
9. Renal Biomarkers Market, by End-User
9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Hospitals
10. Americas Renal Biomarkers Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Renal Biomarkers Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Renal Biomarkers Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. AstraZeneca PLC
14.1.3. Bayer AG
14.1.4. Bio-Rad Laboratories, Inc.
14.1.5. bioMérieux SA
14.1.6. BioPorto Diagnostics A/S
14.1.7. Cipla Limited
14.1.8. Danaher Corporation
14.1.9. DiaSorin S.p.A.
14.1.10. Eli Lilly and Co
14.1.11. Enzo Biochem, Inc.
14.1.12. Eurofins Viracor Inc.
14.1.13. F. Hoffmann-La Roche Ltd.
14.1.14. Fresenius Kabi AG
14.1.15. Novartis AG
14.1.16. Novatein Biosciences Inc.
14.1.17. PerkinElmer Inc.
14.1.18. Randox Laboratories Ltd.
14.1.19. Renalytix AI PLC
14.1.20. Sanofi-Aventis, LLC.
14.1.21. Sekisui Diagnostics, LLC
14.1.22. Siemens Healthineers AG
14.1.23. SphingoTec GmbH
14.1.24. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. RENAL BIOMARKERS MARKET RESEARCH PROCESS
FIGURE 2. RENAL BIOMARKERS MARKET SIZE, 2022 VS 2030
FIGURE 3. RENAL BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RENAL BIOMARKERS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. RENAL BIOMARKERS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. RENAL BIOMARKERS MARKET DYNAMICS
FIGURE 7. RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2022 VS 2030 (%)
FIGURE 8. RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2022 VS 2030 (%)
FIGURE 10. RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 12. RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 14. RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. RENAL BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. RENAL BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. RENAL BIOMARKERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. RENAL BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 6. RENAL BIOMARKERS MARKET SIZE, BY BLOOD UREA NITROGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. RENAL BIOMARKERS MARKET SIZE, BY CREATININE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. RENAL BIOMARKERS MARKET SIZE, BY CYSTATIN C, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. RENAL BIOMARKERS MARKET SIZE, BY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 11. RENAL BIOMARKERS MARKET SIZE, BY ENZYMATIC ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. RENAL BIOMARKERS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY REGION, 2018-2030 (USD MILLION)
TABLE 13. RENAL BIOMARKERS MARKET SIZE, BY TURBIDIMETRIC IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15. RENAL BIOMARKERS MARKET SIZE, BY DIAGNOSIS & DISEASE PROGRESSION MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. RENAL BIOMARKERS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. RENAL BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. RENAL BIOMARKERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. CANADA RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 34. CANADA RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 35. CANADA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. CANADA RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. MEXICO RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 39. MEXICO RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. MEXICO RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. CHINA RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 56. CHINA RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 57. CHINA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CHINA RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. INDIA RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 60. INDIA RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 61. INDIA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. INDIA RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. JAPAN RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 69. JAPAN RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. JAPAN RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. THAILAND RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 93. THAILAND RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. THAILAND RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 105. DENMARK RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 106. DENMARK RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. DENMARK RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. EGYPT RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 110. EGYPT RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. EGYPT RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. FINLAND RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 114. FINLAND RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. FINLAND RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. FRANCE RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 118. FRANCE RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. GERMANY RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 122. GERMANY RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. ITALY RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 130. ITALY RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. ITALY RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. NORWAY RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 142. NORWAY RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NORWAY RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. POLAND RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 145. POLAND RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 146. POLAND RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. POLAND RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. QATAR RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 149. QATAR RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 150. QATAR RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. QATAR RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. SPAIN RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 166. SPAIN RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SPAIN RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. TURKEY RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 178. TURKEY RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. TURKEY RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM RENAL BIOMARKERS MARKET SIZE, BY MARKER TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM RENAL BIOMARKERS MARKET SIZE, BY ASSAY PLATFORM TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM RENAL BIOMARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. RENAL BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 189. RENAL BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 190. RENAL BIOMARKERS MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • AstraZeneca PLC
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • BioPorto Diagnostics A/S
  • Cipla Limited
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Eli Lilly and Co
  • Enzo Biochem, Inc.
  • Eurofins Viracor Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi AG
  • Novartis AG
  • Novatein Biosciences Inc.
  • PerkinElmer Inc.
  • Randox Laboratories Ltd.
  • Renalytix AI PLC
  • Sanofi-Aventis, LLC.
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers AG
  • SphingoTec GmbH
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.43 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.24 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Renal Biomarkers - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Renal Biomarkers - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 119 Pages
  • Global
From
Renal Biomarkers Global Market Report 2024 - Product Image

Renal Biomarkers Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Renal Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Renal Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 190 Pages
  • Global
From
Renal Biomarkers - Global Strategic Business Report - Product Image

Renal Biomarkers - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Renal Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Renal Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 144 Pages
  • Global
From

About the Kidney Marker Market

Biomarkers are biological molecules that can be used to measure and monitor the progression of a disease or condition. Kidney markers are a type of biomarker used to measure the health of the kidneys. They are typically used to diagnose and monitor kidney diseases, such as chronic kidney disease, acute kidney injury, and glomerulonephritis. Kidney markers can also be used to assess the effectiveness of treatments for kidney diseases. Kidney markers are typically measured through blood tests, urine tests, or imaging tests. Commonly used kidney markers include creatinine, cystatin C, and neutrophil gelatinase-associated lipocalin (NGAL). These markers can be used to measure the level of kidney function, as well as to detect the presence of kidney damage. The kidney marker market is a rapidly growing segment of the biomarker market. It is driven by the increasing prevalence of kidney diseases, as well as the growing demand for more accurate and reliable diagnostic tests. The market is expected to continue to grow in the coming years, as new technologies and biomarkers are developed. Some companies in the kidney marker market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Beckman Coulter. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.